Study of Paliperidone ER in Adolescents and Young Adults With Autism
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
This 8-week, prospective open-label study will investigate the effectiveness and tolerability
of paliperidone ER in adolescents and young adults with autism. Hypothesis:Paliperidone Er
will be well tolerated and efficacious for reducing aggression, self-injury, and irritability
in adolescents and young adults.